Strategic Partnerships Leverage Sensome's existing collaboration with Asahi Intecc and Robocath to position co-developed clot characterization and smart guidewire solutions as a turnkey offering for vascular and neurointerventional procedures.

Clinical Validation Exploit ongoing and completed POC studies in cerebral clot characterization to market real-time tissue analysis capabilities as a differentiator for centers performing complex stroke interventions.

Regulatory & Quality Highlight EN ISO 13485:2016 certification to target hospitals and contract manufacturers seeking compliant, high-quality sensing solutions for intravascular devices and device-integration opportunities.

Low-Volume Focus Target mid-market cardiovascular and neurovascular centers with high procedural volume and appetite for innovative guidance technologies, emphasizing faster adoption timelines and potential for early pilot programs.

Growth Through Integration Position Sensome’s impedance-based microsensors as an enabler for next-generation interventional devices, enabling OEMs to differentiate their product lines and create bundled offerings with predictive tissue analysis capabilities.